Vedolizumab
Product Specifications
CAS Number
943609-66-3
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.991
Bioactivity
Vedolizumab, a humanized monoclonal antibody, targets the α4β7 integrin for treating Crohn's disease and ulcerative colitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
